NCBI PubMed Central
open access
Discordance in orphan drug approvals between the U.S. Food and Drug Administration and the European Medicines Agency: A retrospective observational analysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Suchtforschungsverbund Bayern/Dresden "Allocating Substance Abuse Treatments to Patient Heterogeneity" (ASAT) : Schlußbericht 2004 ; Zuwendungsempfänger: 1. Technische Universität Dresden, Förderkennzeichen 01 EB 0140, Laufzeit des Vorhabens: 01.11.2001 - 31.10.2004; 2. IFT Institut für Therapieforschung München, Förderkennzeichen 01 EB 0141, Laufzeit des Vorhabens: 01.11.2001 - 31.10.2004; 3. Ludwig-Maximilians-Universität München, Förderkennzeichen: 01 EB 0142, Laufzeit des Vorhabens: 01.06.2002 - 31.10.2004#129694
- 21 U.S.C. § 356c — Discontinuance or interruption in the production of life-saving drugs#577377
- A large randomized trial assessing alcohol cessation versus moderation on clinical events: UNATI.#421227
- Trends in Medicines Discontinuation and Implications for Access in Brazil (2014-2024).#480876
- Decreasing Criminal Legal System Referrals to Cannabis Treatment in the U.S.: Adolescent Trends by Race and Ethnicity Between 2010 and 2022.#396735
Record · ID 375307
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive